525 related articles for article (PubMed ID: 29025463)
1. Clinical efficacy of immunotherapy in allergic rhinitis.
Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
[TBL] [Abstract][Full Text] [Related]
2. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
Creticos PS; Gunaydin FE; Nolte H; Damask C; Durham SR
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1415-1427. PubMed ID: 38685477
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
Yang J; Lei S
Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
7. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
8. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
[TBL] [Abstract][Full Text] [Related]
10. Treating allergic rhinitis by sublingual immunotherapy: a review.
Incorvaia C; Di Rienzo A; Celani C; Makrì E; Frati F
Ann Ist Super Sanita; 2012; 48(2):172-6. PubMed ID: 22751560
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Allergen Immunotherapy in Allergic Rhinitis.
Drazdauskaitė G; Layhadi JA; Shamji MH
Curr Allergy Asthma Rep; 2020 Dec; 21(1):2. PubMed ID: 33313967
[TBL] [Abstract][Full Text] [Related]
12. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
13. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
14. Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance study.
Frati F; Beni N; Marastoni L; Compalati E; Ciprandi G
Immunotherapy; 2024 Jan; 16(1):43-53. PubMed ID: 38018469
[TBL] [Abstract][Full Text] [Related]
15. A bright future for sublingual immunotherapy--contra.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):242-50; discussion 250-2. PubMed ID: 17393746
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Lin SY; Erekosima N; Kim JM; Ramanathan M; Suarez-Cuervo C; Chelladurai Y; Ward D; Segal JB
JAMA; 2013 Mar; 309(12):1278-88. PubMed ID: 23532243
[TBL] [Abstract][Full Text] [Related]
17. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.
Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C
Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728
[TBL] [Abstract][Full Text] [Related]
18. The Art of Immunotherapy.
Nelson HS
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):1-10. PubMed ID: 37898175
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.
Reider N
Int Arch Allergy Immunol; 2005 Jul; 137(3):181-6. PubMed ID: 15947473
[TBL] [Abstract][Full Text] [Related]
20. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
Scheinmann P; Pham Thi N; Karila C; de Blic J
Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
